FADD Expression as a Prognosticator in Early-Stage Glottic Squamous Cell Carcinoma of the Larynx Treated Primarily With Radiotherapy

Article ID	Journal	Published Year	Pages	File Type
8225740	International Journal of Radiation OncologyBiologyPhysics	2012	7 Pages	PDF

Abstract

This study showed that expression of phosphorylated FADD is a new prognostic biomarker for better local control after radiotherapy in patients with early-stage glottic carcinomas.

Keywords

FADD Larynx Radiotherapy Prognostic marker Squamous cell carcinoma

Related Topics

Physical Sciences and Engineering Physics and Astronomy Radiation

Preview

FADD Expression as a Prognosticator in Early-Stage Glottic Squamous Cell Carcinoma of the Larynx Treated Primarily With Radiotherapy

Authors

Michiel L. M.D., Wouter J. M.Sc., Lorian B.Sc., Mirjam F. B.Sc., Johan H. Ph.D., Johannes A. M.D., Ph.D., Jacqueline E. M.D., D.M.D., Ph.D., Bernard F.A.M. M.D., Ph.D., E. Ph.D.,